Plain-English translation of NCT03014609 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study—meaning researchers will monitor and measure your health over time rather than give you a new medication. The study aims to understand why people with chronic lung disease have higher rates of heart disease and death, by tracking inflammation, stress markers, and how your heart and muscles function over a five-year period.
People with chronic lung disease face a much higher risk of heart disease and heart-related death, but doctors don't fully understand why. This study will help identify the key factors that link lung disease to heart risk, which could eventually lead to better ways to prevent and treat heart problems in this population.
You likely qualify if…
You likely don't qualify if…
You will be part of a long-term observation study lasting five years, during which researchers will track your heart and lung health through regular tests and measurements. This may include breathing tests, blood work to check inflammation and stress markers, heart function assessments, and muscle strength evaluations. You won't be taking a new medication; instead, doctors will monitor how your existing condition evolves and what factors influence your heart disease risk over time.
AI-generated summary from trial data · Jun 20, 2026 · Not medical advice
France
Sponsor
University Hospital, Grenoble
Enrollment target
~150 participants
Started
January 2017
Primary completion
November 2029
Age range
18 Years – 85 Years
Last updated on clinicaltrials.gov in May 2023.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jean-Louis PEPIN, ProfessorPHD
University Grenoble Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.